Bluefish Pharmaceuticals AB-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Bluefish Pharmaceuticals AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011855
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bluefish Pharmaceuticals AB (Bluefish Pharmaceuticals) is a manufacturer and distributor of generic pharmaceutical products. The company provides products for various therapeutic areas including cardiovascular, the central nervous system, gastrointestinal, diabetes, oncology, dermatology, respiratory, inflammatory, genito-urinary, antifungal, antiviral, endocrinology, analgesic and antibiotics, among others. Its product development process includes product selection, geographic access, costs, supply chain operations and intellectual property rights. Bluefish Pharmaceuticals’ product are used in the treatment of diabetes, breast cancer, depression and anxiety disorders, seizures, migraine headaches, panic attacks, schizophrenia and schizophrenia, among others. The company has collaboration with development and manufacturing companies. Bluefish Pharmaceuticals is headquartered in Stockholm, Sweden.

Bluefish Pharmaceuticals AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Bluefish Pharma Enters Into Licensing Agreement For Two Products 10
Bluefish Pharma Enters Into Licensing Agreement For Fifteen Products 11
Equity Offering 12
Bluefish Pharma Completes Private Placement Of Shares For US$6.2 Million 12
Bluefish Pharma Completes Private Placement Of Shares For US$11.8 Million 13
Bluefish Pharma Completes Private Placement Of Shares For US$2.8 Million 14
Bluefish Pharma Completes Private Placement Of Shares For US$6 Million 15
Debt Offering 16
Bluefish Pharma Completes Convertible Bond Issue For US$6.1 Million 16
Acquisition 17
Bluefish Pharma Acquires BMM Pharma From BioPhausia 17
Bluefish Pharmaceuticals AB – Key Competitors 18
Bluefish Pharmaceuticals AB – Key Employees 19
Bluefish Pharmaceuticals AB – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Nov 20, 2017: Bluefish Pharmaceuticals: Interim Report January-September 2017 22
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Key Facts 2
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bluefish Pharmaceuticals AB, Deals By Therapy Area, 2011 to YTD 2017 8
Bluefish Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Bluefish Pharma Enters Into Licensing Agreement For Two Products 10
Bluefish Pharma Enters Into Licensing Agreement For Fifteen Products 11
Bluefish Pharma Completes Private Placement Of Shares For US$6.2 Million 12
Bluefish Pharma Completes Private Placement Of Shares For US$11.8 Million 13
Bluefish Pharma Completes Private Placement Of Shares For US$2.8 Million 14
Bluefish Pharma Completes Private Placement Of Shares For US$6 Million 15
Bluefish Pharma Completes Convertible Bond Issue For US$6.1 Million 16
Bluefish Pharma Acquires BMM Pharma From BioPhausia 17
Bluefish Pharmaceuticals AB, Key Competitors 18
Bluefish Pharmaceuticals AB, Key Employees 19
Bluefish Pharmaceuticals AB, Subsidiaries 20

★海外企業調査レポート[Bluefish Pharmaceuticals AB-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CSA Medical Inc-医療機器分野:企業M&A・提携分析
    Summary CSA Medical Inc (CSA Medical) is a medical device company that offers cryotherapy devices. The company provides spray cryotherapy medical device solutions to improve patient outcomes, simplify procedures, and reduce the cost of healthcare. Its truFreeze system delivers cold liquid nitrogen s …
  • Parque Arauco S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Parque Arauco S.A. Mergers and …
  • ACTIVE Network, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' ACTIVE Network, LLC Mergers and …
  • Dcns S.A.:企業のM&A・提携動向(エネルギー分野)
    Summary Dcns S.A.(Dcns) formerly Direction des Constructions Navales is a naval defense equipment manufacturing company that designs, builds and supports naval defense systems. The company’s products include submarines, warships, surface combatants and associated systems and infrastructures. It offe …
  • Warrnambool Cheese and Butter Factory Company Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Warrnambool Cheese and Butter F …
  • Kimura Unity Co., Ltd. (9368):企業概要、財務及び戦略的SWOT分析
    Summary KIMURA UNITY CO., LTD. (KIMURA) is a business and consumer service provider. The company offers logistics services, car services, information services, and staffing services. Its logistics services include outsourcing and contract work, logistics system development, and distribution equipmen …
  • Colfax Corporation (CFX):企業のM&A・提携動向(石油・ガス分野)
    Summary Colfax Corporation (Colfax) is an industrial engineering company. It develops, manufactures and distributes gas- and fluid-handling and fabrication technology products and related services to industrial, government and commercial customers. The company offers products for use in cutting and …
  • Ning Xia Yin Xing Energy Co., Ltd. (000862):企業概要、財務及び戦略的SWOT分析
    Summary Ning Xia Yin Xing Energy Co., Ltd. (Ningxia) is a renewable energy service company. The company’s main businesses are renewable energy generation and renewable energy equipment manufacturing. Its renewable energy equipment manufacturing consists of wind power equipment manufacturing and sola …
  • UTStarcom Holdings Corp. (UTSI):企業の財務・戦略的SWOT分析
    UTStarcom Holdings Corp. (UTSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Daihatsu Motor Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryDaihatsu Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • QuadraMed Corp:企業の戦略的SWOT分析
    QuadraMed Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Arana Therapeutics Limited (formerly Peptech Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Arana Therapeutics Limited (for …
  • Aeglea BioTherapeutics Inc (AGLE)-製薬・医療分野:企業M&A・提携分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …
  • Rockhopper Exploration PLC (RKH)(石油・ガス分野):企業M&A動向
    Summary Rockhopper Exploration plc (Rockhopper) is an oil and gas exploration company. It focuses on exploration and production of crude oil and natural gas. The company discovered oil in the Falkland Islands, located in the South Atlantic Ocean and holds a number of production licenses. It holds as …
  • Sahara Energy Ltd. (SAH):企業概要、財務及び戦略的SWOT分析
    Summary Sahara Energy Ltd. (Sahara Energy) is an oil and gas exploration company. The company acquires, explores, exploits and develops oil and natural gas. It has oil and gas exploration assets in Lloydminster, Alberta, Western Saskatchewan, Central Alberta, and Southern Alberta. Sahara Energy deve …
  • Banco Pine SA (PINE4):企業概要、財務及び戦略的SWOT分析
    Summary Banco Pine SA (Banco Pine) is a financial institution. The institution offers credit and financing, onlending and securitization products. It provides various banking services to its customers. The institution conducts activities such as corporate lending, FICC, PINE investments, distributio …
  • Chambal Fertilisers and Chemicals Limited (CHAMBLFERT):企業の財務及び戦略的SWOT分析
    Summary Chambal Fertilisers and Chemicals Limited (CFCL) is a chemical company that manufactures agro-chemicals. The company supplies urea and other agri-inputs like MOP (Murate of Potash), DAP (Di-Ammonium Phosphate), SSP (Single Super Phosphate), pesticides and seeds. Its fertilizer products inclu …
  • Concord Medical Services Holdings Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Concord Medical Services Holdin …
  • Sequa Corporation:企業の戦略・SWOT・財務分析
    SummarySequa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Grupo Famsa, S.A.B. de C.V.:戦略・SWOT・企業財務分析
    Grupo Famsa, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Famsa, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆